14 research outputs found
Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet
<p>Abstract</p> <p>Background</p> <p>Statins are first-line pharmacotherapeutic agents for hypercholesterolemia treatment in humans. However the effects of statins on atherosclerosis in mouse models are very paradoxical. In this work, we wanted to evaluate the effects of simvastatin on serum cholesterol, atherogenesis, and the expression of several factors playing important roles in reverse cholesterol transport (RCT) in apoE-/- mice fed a high-fat diet.</p> <p>Results</p> <p>The atherosclerotic lesion formation displayed by oil red O staining positive area was reduced significantly by 35% or 47% in either aortic root section or aortic arch en face in simvastatin administrated apoE-/- mice compared to the control. Plasma analysis by enzymatic method or ELISA showed that high-density lipoprotein-cholesterol (HDL-C) and apolipoprotein A-I (apoA-I) contents were remarkably increased by treatment with simvastatin. And plasma lecithin-cholesterol acyltransferase (LCAT) activity was markedly increased by simvastatin treatment. Real-time PCR detection disclosed that the expression of several transporters involved in reverse cholesterol transport, including macrophage scavenger receptor class B type I, hepatic ATP-binding cassette (ABC) transporters ABCG5, and ABCB4 were induced by simvastatin treatment, the expression of hepatic ABCA1 and apoA-I, which play roles in the maturation of HDL-C, were also elevated in simvastatin treated groups.</p> <p>Conclusions</p> <p>We demonstrated the anti-atherogenesis effects of simvastatin in apoE-/- mice fed a high-fat diet. We confirmed here for the first time simvastatin increased the expression of hepatic ABCB4 and ABCG5, which involved in secretion of cholesterol and bile acids into the bile, besides upregulated ABCA1 and apoA-I. The elevated HDL-C level, increased LCAT activity and the stimulation of several transporters involved in RCT may all contribute to the anti-atherosclerotic effect of simvastatin.</p
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Abstract Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent bonds on the backbones or amino acid side chains of proteins and expand the diversity of proteins, which provides the basis for the emergence of organismal complexity. To date, more than 650 types of protein modifications, such as the most well‐known phosphorylation, ubiquitination, glycosylation, methylation, SUMOylation, short‐chain and long‐chain acylation modifications, redox modifications, and irreversible modifications, have been described, and the inventory is still increasing. By changing the protein conformation, localization, activity, stability, charges, and interactions with other biomolecules, PTMs ultimately alter the phenotypes and biological processes of cells. The homeostasis of protein modifications is important to human health. Abnormal PTMs may cause changes in protein properties and loss of protein functions, which are closely related to the occurrence and development of various diseases. In this review, we systematically introduce the characteristics, regulatory mechanisms, and functions of various PTMs in health and diseases. In addition, the therapeutic prospects in various diseases by targeting PTMs and associated regulatory enzymes are also summarized. This work will deepen the understanding of protein modifications in health and diseases and promote the discovery of diagnostic and prognostic markers and drug targets for diseases
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
Abstract The progression of urothelial bladder cancer (UC) is a complicated multi-step process. We perform a comprehensive multi-omics analysis of 448 samples from 190 UC patients, covering the whole spectrum of disease stages and grades. Proteogenomic integration analysis indicates the mutations of HRAS regulated mTOR signaling to form urothelial papilloma rather than papillary urothelial cancer (PUC). DNA damage is a key signaling pathway in the progression of carcinoma in situ (CIS) and related to APOBEC signature. Glucolipid metabolism increase and lower immune cell infiltration are associated with PUC compared to CIS. Proteomic analysis distinguishes the origins of invasive tumors (PUC-derived and CIS-derived), related to distinct clinical prognosis and molecular features. Additionally, loss of RBPMS, associated with CIS-derived tumors, is validated to increase the activity of AP-1 and promote metastasis. This study reveals the characteristics of two distinct branches (PUC and CIS) of UC progression and may eventually benefit clinical practice
Genome-Wide Analysis of the NAC Domain Transcription Factor Gene Family in Theobroma cacao
Nursing of a patient with type 2 diabetes mellitus complicated with invasive pulmonary aspergillosis resulting in the formation of a cavity in the upper lobe of the right lung causing hemoptysis (1例2型糖尿病合并侵袭性肺曲霉菌病致右肺上叶空洞形成致大咯血患者的护理体会)
This paper summarized the nursing of a patient with type 2 diabetes mellitus complicated with invasive pulmonary aspergillosis resulting in the formation of a cavity in the upper lobe of the right lung causing hemoptysis. Nurses had closely observe the changes in the patient's condition and carried out comprehensive interventions including hemoptysis care, dietary care, disinfection and isolation, cough and sputum production and oxygen therapy care, Traditional Chinese Medicine nursing, psychological care and health education. Efforts were made to reduce the risk of hemoptysis, control the blood glucose, improve immunity and quality of life of the patient. (本文总结1例2型糖尿病合并侵袭性肺曲霉菌病导致右肺上叶空洞形成致大咯血患者的护理的经验。患入院后密切观察病情变化, 给予咯血护理、饮食护理、消毒隔离、咳嗽咳痰及氧疗护理、中医护理、心理护理以及健康宣教, 降低患者咯血风险, 积极控制血糖, 增强机体抵抗力, 提高生活质量。
A turn-on fluorescent probe for real-time detection of endogenous cysteine in living cells
mRNA-Laden Lipid-Nanoparticle-Enabled <i>in Situ</i> CAR-Macrophage Engineering for the Eradication of Multidrug-Resistant Bacteria in a Sepsis Mouse Model
Sepsis, which is the most severe
clinical manifestation of acute
infection and has a mortality rate higher than that of cancer, represents
a significant global public health burden. Persistent methicillin-resistant Staphylococcus aureus (MRSA) infection and further host
immune paralysis are the leading causes of sepsis-associated death,
but limited clinical interventions that target sepsis have failed
to effectively restore immune homeostasis to enable complete eradication
of MRSA. To restimulate anti-MRSA innate immunity, we developed CRV
peptide-modified lipid nanoparticles (CRV/LNP-RNAs) for transient in situ programming of macrophages (MΦs). The CRV/LNP-RNAs
enabled the delivery of MRSA-targeted chimeric antigen receptor (CAR)
mRNA (SasA-CAR mRNA) and CASP11 (a key MRSA intracellular evasion
target) siRNA to MΦs in situ, yielding CAR-MΦs
with boosted bactericidal potency. Specifically, our results demonstrated
that the engineered MΦs could efficiently phagocytose and digest
MRSA intracellularly, preventing immune evasion by the “superbug”
MRSA. Our findings highlight the potential of nanoparticle-enabled in vivo generation of CAR-MΦs as a therapeutic platform
for multidrug-resistant (MDR) bacterial infections and should be confirmed
in clinical trials